Checkmate Pharmaceuticals

Checkmate Pharmaceuticals

Developing a new approach for cancer immunotherapy.

Launch date
Employees
Market cap
-
Enterprise valuation
$340—510m (Dealroom.co estimates Jun 2020.)
Cambridge Massachusetts (HQ)
Authorizing premium user...